AstraZeneca PLCAZNNASDAQ
Loading
Debt Growth Under PressureDecelerating
Percentile Rank3
Year-over-Year Change
Year-over-year debt growth rate
Percentile
P3
Near historical low
vs 2Y Ago
-56.3x
Contraction
Streak
3 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -9.06% |
| Q3 2025 | -0.54% |
| Q2 2025 | 3.54% |
| Q1 2025 | 5.32% |
| Q4 2024 | -4.59% |
| Q3 2024 | -5.88% |
| Q2 2024 | -2.95% |
| Q1 2024 | 20.71% |
| Q4 2023 | 0.16% |
| Q3 2023 | -4.23% |
| Q2 2023 | -5.29% |
| Q1 2023 | 7.77% |
| Q4 2022 | -0.23% |
| Q3 2022 | -0.78% |
| Q2 2022 | -5.05% |
| Q1 2022 | 1.03% |
| Q4 2021 | -3.54% |
| Q3 2021 | 16.06% |
| Q2 2021 | 36.57% |
| Q1 2021 | -1.22% |
| Q4 2020 | -8.77% |
| Q3 2020 | 13.13% |
| Q2 2020 | 6.30% |
| Q1 2020 | 1.91% |
| Q4 2019 | 0.38% |
| Q3 2019 | -7.85% |
| Q2 2019 | -8.68% |
| Q1 2019 | 12.90% |
| Q4 2018 | -8.61% |
| Q3 2018 | 6.34% |
| Q2 2018 | -0.94% |
| Q1 2018 | 11.50% |
| Q4 2017 | -0.25% |
| Q3 2017 | -9.50% |
| Q2 2017 | 13.35% |
| Q1 2017 | 3.53% |
| Q4 2016 | -4.95% |
| Q3 2016 | 0.59% |
| Q2 2016 | 7.77% |
| Q1 2016 | 8.36% |